Veteran PTSD Research Study
Brown University is conducting a research study to explore MDMA-Assisted Psychotherapy for U.S. Veterans with PTSD who drink alcohol.
Fast Facts
Symptoms or Diagnosis of PTSD and Uses Alcohol
U.S. Veteran
MDMA-Assisted Therapy
11-Week Course of Treatment
Study Background
Exploring MDMA-assisted therapy for PTSD and alcohol use in U.S. Veterans
This study is focused on understanding the potential of MDMA-assisted psychotherapy as a treatment for U.S. Veterans dealing with PTSD and alcohol use. MDMA, a psychedelic substance, has shown promise in clinical trials as an effective tool when paired with psychotherapy to alleviate symptoms of PTSD. By examining its effects specifically in Veterans, we aim to gather critical data on how this treatment approach can offer emotional healing and practical support for those affected by these conditions.
Our study is designed to assess both the feasibility and acceptability of MDMA-assisted therapy for Veterans, as well as its potential to improve PTSD and alcohol use outcomes. Participants will engage in an 11-week therapy program, including two MDMA sessions with licensed psychotherapists, providing valuable insight into whether this novel approach can help Veterans on their path to recovery.
Study Background
Exploring MDMA-assisted therapy for PTSD and alcohol use in U.S. Veterans.
This study is focused on understanding the potential of MDMA-assisted psychotherapy as a treatment for U.S. Veterans dealing with PTSD and alcohol use. MDMA, a psychedelic substance, has shown promise in clinical trials as an effective tool when paired with psychotherapy to alleviate symptoms of PTSD. By examining its effects specifically in Veterans, we aim to gather critical data on how this treatment approach can offer emotional healing and practical support for those affected by these conditions.
Our study is designed to assess both the feasibility and acceptability of MDMA-assisted therapy for Veterans, as well as its potential to improve PTSD and alcohol use outcomes. Participants will engage in an 11-week therapy program, including two MDMA sessions with licensed psychotherapists, providing valuable insight into whether this novel approach can help Veterans on their path to recovery.
Additional Information
You may qualify for a study if you meet the following criteria:
Inclusion Criteria:
- U.S. Veteran
- Diagnosed with or experiencing symptoms of PTSD
- Currently using alcohol
- Able to attend weekly 90-minute therapy appointments and two 8-hour MDMA sessions
- Have a support person available to escort you home after MDMA sessions
Exclusion Criteria:
- Cardiac health issues
- Not a U.S. Veteran
- Currently using substances other than nicotine, caffeine, or cannabis
If you participate in this study, you will undergo an 11-week course of MDMA-assisted therapy, guided by licensed psychotherapists. This will include weekly 90-minute therapy sessions, with two of those sessions involving 8 hours of MDMA-assisted therapy. Throughout the study, you’ll be closely monitored, and you’ll have a follow-up visit for data collection.
Eligible participants will receive up to $200 in compensation ($100 upon enrollment and $100 upon completion), with validated parking, Uber, or public transit reimbursement provided.
There is no cost for you to participate in our research study.
